IntrinsicIntrinsic
← All summaries

Abony Acquisition Corp. I

AACOU
Financials & Chart →

Business Summary

Abony Acquisition Corp. I is a blank check company incorporated in the Cayman Islands on November 13, 2025, formed with the sole purpose of effecting a business combination such as a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar transaction with one or more businesses . The company has not yet selected any specific target business and has not engaged in substantive discussions with any potential targets . The company intends to focus on businesses with an aggregate enterprise value of approximately $750 million to $1.5 billion or more, particularly those that complement its management team's background in defense technology, advanced computing, software, and media industry sectors .

The core business model of Abony Acquisition Corp. I is to identify and acquire a target business, effectively taking it public through a business combination. The company generates no operating revenue currently, with its activities from inception through December 31, 2025, limited to organizational activities and preparations for its initial public offering (IPO), and subsequently, identifying a target company . Post-IPO, the company expects to generate non-operating income from interest earned on cash held in its trust account . Revenue generation from operations is not anticipated until after the completion of a business combination .

The company's management team, led by Lorne Abony (CEO and Director) and Leo Kofman (CFO and COO), brings experience in operating, investment, and SPAC transactions . Mr. Abony has a track record of scaling public companies and has raised over $10 billion in capital through public and private debt and equity markets . Mr. Kofman has advised on over $10 billion in capital raises, including over $1.5 billion in private investment in public equity (PIPE) capital raises for SPAC business combinations . The company believes its team's expertise and network will be crucial in identifying and executing a successful business combination and supporting the combined entity post-acquisition .

For the period from November 13, 2025 (inception) through December 31, 2025, Abony Acquisition Corp. I reported a net loss of $99,715 , which consisted entirely of general and administrative costs . As of December 31, 2025, the company had no cash and a working capital deficit of $425,990 . Total assets were $391,275 , comprising $40,000 in prepaid expenses and $351,275 in deferred offering costs . Total liabilities amounted to $465,990 , including $33,875 in accrued expenses , $307,325 in accrued offering costs , and a promissory note to a related party of $124,790 . The shareholder's deficit was $(74,715) , with 7,666,667 Class B ordinary shares issued and outstanding . Basic and diluted net loss per share for the period was $(0.01) , based on 6,666,667 basic and diluted weighted average shares outstanding .

Subsequent to the reporting period, on February 20, 2026, the company completed its IPO, selling 23,000,000 units at $10.00 per unit, generating gross proceeds of $230,000,000 . Simultaneously, 695,000 private placement units were sold to the sponsor and BTIG, LLC at $10.00 per unit, generating gross proceeds of $6,950,000 . A total of $230,000,000 from the IPO and private placement proceeds, including $8,050,000 of deferred underwriting commissions, was placed in a U.S.-based trust account . Total transaction costs incurred were $13,314,254, consisting of a $4,600,000 cash underwriting fee, $8,050,000 deferred underwriting fee, and $664,254 in other offering costs .

Business Outlook

Abony Acquisition Corp. I intends to use substantially all of the funds held in the trust account, including any interest earned (less income taxes payable), to complete its business combination . If share capital or debt is used as consideration, the remaining proceeds in the trust account will serve as working capital for the target business's operations, future acquisitions, and growth strategies . Funds held outside the trust account are primarily designated for identifying and evaluating target businesses, conducting due diligence, travel, reviewing corporate documents, and structuring and negotiating a business combination .

The company's growth strategy is centered on capitalizing on the significant experience, network, and reach of its management team and directors to identify and complete an initial business combination with a target business that is expected to create shareholder value in the public markets . The target sectors include defense technology, advanced computing, software, and media industry sectors, with an approximate enterprise value of $750 million to $1.5 billion or more . The management team's collective experience and capital markets expertise are expected to facilitate the business combination and provide ongoing support to the combined company .

The company anticipates incurring significant costs in the pursuit of its acquisition plans . To fund working capital deficiencies or transaction costs, the sponsor or its affiliates, or certain officers and directors, may provide loans, up to $1,500,000, which may be convertible into private placement units at $10.00 per unit upon completion of a business combination . The company does not believe it will need to raise additional funds to meet operating expenditures, but acknowledges that if its cost estimates for identifying and negotiating a target are inaccurate, it may have insufficient funds or need additional financing, potentially through issuing more securities or incurring debt .

The company has a completion window of 24 months from the closing of its IPO, or an earlier liquidation date approved by its board, to consummate an initial business combination . While there is no current intention to seek shareholder approval for an extension, the company may elect to do so, with no limit on the number of extensions, though it does not expect to extend beyond 36 months from the IPO closing . If an extension is sought, public shareholders would have the opportunity to redeem their shares at a per-share price equal to the aggregate amount in the trust account (less taxes payable) .

Risk Factors

The company faces several material risks, including the possibility that public shareholders may not have an opportunity to vote on a proposed business combination, and even if a vote occurs, the sponsor's significant ownership (25% of outstanding ordinary shares ) and agreement to vote in favor could lead to approval despite public shareholder dissent . The ability of public shareholders to redeem shares for cash may make the company's financial condition unattractive to potential targets, potentially hindering the completion of a desirable business combination or optimizing its capital structure, and could substantially dilute non-redeeming shareholders . The requirement to complete a business combination within a 24-month completion window may give target businesses leverage in negotiations and limit due diligence time, particularly as the deadline approaches . Changes in laws or regulations, such as the SEC's new SPAC Rules, may increase costs and time needed for a business combination and could lead to the company being deemed an investment company under the Investment Company Act, imposing burdensome compliance requirements or restricting activities . Geopolitical conditions, including military escalations between the United States and Iran, and the ongoing Russia-Ukraine conflict, could adversely affect global economies, capital markets, and the pool of viable target candidates . The company may also face risks if it acquires a target whose business model is disrupted or made obsolete by advancements in artificial intelligence and machine learning . If the company fails to complete an initial business combination, public shareholders may only receive their pro rata portion of the trust account funds, and warrants will expire worthless . The nominal purchase price paid by the sponsor for founder shares (approximately $0.003 per share ) could result in significant dilution to public shareholders and a substantial profit for the sponsor even if the combined company's value declines .

Management Priorities

Management's message emphasizes leveraging the team's extensive operating, investment, and SPAC experience to identify and execute a successful business combination. The strategic priorities include focusing on target companies with an enterprise value of approximately $750 million to $1.5 billion or more in sectors such as defense technology, advanced computing, software, and media . Management intends to capitalize on its network and capital markets expertise to source attractive opportunities and provide operational guidance and support to enhance growth and value creation for the combined public company . The company expects to incur significant costs in pursuing its acquisition plans and will use funds from the trust account, including interest earned (less income taxes payable), to complete the business combination . The sponsor or affiliates may provide working capital loans up to $1,500,000 , convertible into private placement units at $10.00 per unit , to finance transaction costs or working capital deficiencies.

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — General
  2. [2] Item 1, Business — Note 1 — Organization and Business Operations
  3. [3] Item 1, Business — General
  4. [4] Item 7, MD&A — Results of Operations
  5. [5] Item 7, MD&A — Results of Operations
  6. [6] Item 7, MD&A — Results of Operations
  7. [7] Item 1, Business — Our Management Team
  8. [8] Item 1, Business — Our Competitive Strengths
  9. [9] Item 1, Business — Our Competitive Strengths
  10. [10] Item 1, Business — Business Strategy
  11. [11] Item 7, MD&A — Results of Operations
  12. [12] Item 7, MD&A — Results of Operations
  13. [13] Item 7, MD&A — Liquidity and Capital Resources
  14. [14] Item 7, MD&A — Liquidity and Capital Resources
  15. [15] Item 8, Balance Sheet — Total Assets
  16. [16] Item 8, Balance Sheet — Prepaid expenses
  17. [17] Item 8, Balance Sheet — Deferred offering costs
  18. [18] Item 8, Balance Sheet — Total Liabilities
  19. [19] Item 8, Balance Sheet — Accrued expenses
  20. [20] Item 8, Balance Sheet — Accrued offering costs
  21. [21] Item 8, Balance Sheet — Promissory note - related party
  22. [22] Item 8, Balance Sheet — Total Shareholder’s Deficit
  23. [23] Item 8, Balance Sheet — Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,666,667 shares issued and outstanding
  24. [24] Item 8, Statement of Operations — Basic and diluted net loss per share, Class B ordinary shares
  25. [25] Item 8, Statement of Operations — Basic and diluted weighted average shares outstanding, Class B ordinary shares
  26. [26] Item 7, MD&A — Liquidity and Capital Resources
  27. [27] Item 7, MD&A — Liquidity and Capital Resources
  28. [28] Item 7, MD&A — Liquidity and Capital Resources
  29. [29] Item 7, MD&A — Liquidity and Capital Resources
  30. [30] Item 7, MD&A — Liquidity and Capital Resources
  31. [31] Item 7, MD&A — Liquidity and Capital Resources
  32. [32] Item 7, MD&A — Liquidity and Capital Resources
  33. [33] Item 1, Business — Business Strategy
  34. [34] Item 1, Business — General
  35. [35] Item 1, Business — Business Strategy
  36. [36] Item 1, Business — General
  37. [37] Item 7, MD&A — Liquidity and Capital Resources
  38. [38] Item 7, MD&A — Liquidity and Capital Resources
  39. [39] Item 1, Business — Initial Business Combination
  40. [40] Item 1, Business — Initial Business Combination
  41. [41] Item 1, Business — Initial Business Combination
  42. [42] Item 1A, Risk Factors — Our sponsor owns 25% of our outstanding ordinary shares
  43. [43] Item 1A, Risk Factors — Our public shareholders may not be afforded an opportunity to vote on our proposed initial business combination, and even if we hold a vote, (i) holders of our founder shares will participate in such vote, which means we may complete our initial business combination even though a majority of our public shareholders do not support such a combination and (ii) if the non-managing sponsor investors vote in favor of an initial business combination, we may not need any public shares sold to other investors to be voted in favor of the initial business combination.
  44. [44] Item 1A, Risk Factors — The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target.
  45. [45] Item 1A, Risk Factors — The requirement that we complete our initial business combination within the completion window may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our shareholders.
  46. [46] Item 1A, Risk Factors — Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations.
  47. [47] Item 1A, Risk Factors — Our search for an initial business combination, and any target business with which we may ultimately consummate an initial business combination, may be materially adversely affected by current global geopolitical conditions resulting from the military escalation between the United States and Iran, the ongoing Russia-Ukraine conflict, and other similar geopolitical conflicts.
  48. [48] Item 1A, Risk Factors — Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by new outbreaks, or continuation of any existing outbreaks, of any infectious disease (such as COVID-19), the status of debt and equity markets and disruption of target business models or potential obsolescence by artificial intelligence.
  49. [49] Item 1A, Risk Factors — If we are unable to complete our initial business combination, our public shareholders may receive only their pro rata portion of the funds in the trust account that are available for distribution to public shareholders, and our warrants will expire worthless.
  50. [50] Item 1A, Risk Factors — The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline.
  51. [51] Item 1A, Risk Factors — The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline.
  52. [52] Item 1, Business — General
  53. [53] Item 1, Business — General
  54. [54] Item 1, Business — Business Strategy
  55. [55] Item 1, Business — General
  56. [56] Item 7, MD&A — Liquidity and Capital Resources
  57. [57] Item 7, MD&A — Liquidity and Capital Resources
  58. [58] Item 7, MD&A — Liquidity and Capital Resources

Analysis on 5/22/2026